Irish Life Investment Managers’s Acadia Pharmaceuticals ACAD Stock Holding History

Irish Life Investment Managers’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$59.8K	Buy	+3,295	New	+$45.4K	﹤0.01%	1241

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's ACAD Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2013: 3,295 shares worth $59.8K. The stake represents ﹤0.01% of the portfolio and ranks #1241 among its holdings.

123 funds tracked by Wall St. Rank hold ACAD as of Q2 2013.

Irish Life Investment Managers held 3,295 shares of Acadia Pharmaceuticals worth $59.8K as of Q2 2013.
Acadia Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Acadia Pharmaceuticals made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1241 holding.
123 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.